⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27825550 | 0.84 | — | — | |
| SCHEMBL10589970 | 0.81 | — | — | |
| SCHEMBL27871553 | 0.78 | — | — | |
| SCHEMBL208361 | 0.77 | SPHK1 (0.35) | — | |
| SCHEMBL942111 | 0.77 | — | — | |
| SCHEMBL7644867 | 0.76 | — | — | |
| SCHEMBL7644868 | 0.76 | — | — | |
| SCHEMBL13703341 | 0.76 | — | — | |
| SCHEMBL28728217 | 0.76 | — | — | |
| SCHEMBL13703384 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124492-A1 | Amino-triazolopyridine Compounds and Their Use in Treating Cancer | ASTRAZENECA AB (SE) | 2024-04-18 | — | — | US | disclosed |
| US-11746118-B2 | Amino-triazolopyridine compounds and their use in treating cancer | ASTRAZENECA AB (SE) | 2023-09-05 | — | — | US | disclosed |
| WO-2021260583-A1 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND DNA-PK INHIBITOR | ASTRAZENECA UK LIMITED (GB) | 2021-12-30 | — | — | WO | disclosed |
| US-11136340-B2 | Amino-triazolopyridine compounds and their use in treating cancer | ASTRAZENECA AB (SE) | 2021-10-05 | — | — | US | disclosed |
| EP-3558997-B1 | AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB (SE) | 2021-01-27 | — | — | EP | disclosed |
| US-20200048281-A1 | Amino-triazolopyridine Compounds and Their Use in Treating Cancer | ASTRAZENECA UK LIMITED (GB) | 2020-02-13 | — | — | US | disclosed |
| EP-3558997-A1 | AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER | Astrazeneca AB (SE) | 2019-10-30 | — | — | EP | disclosed |
| CN-105652623-B | Image forming apparatus, handle box and image forming method | 佳能株式会社 | 2019-09-24 | — | — | CN | disclosed |
| US-10407446-B2 | Amino-triazolopyridine compounds and their use in treating cancer | ASTRAZENECA AB (SE) | 2019-09-10 | — | — | US | disclosed |
| US-20180194782-A1 | Amino-triazolopyridine Compounds and Their Use in Treating Cancer | ASTRAZENECA UK LIMITED (GB) | 2018-07-12 | — | — | US | disclosed |
| CN-100504626-C | Toner | CANON KK (JP) | 2009-06-24 | — | — | CN | disclosed |
| CN-101454307-A | Mixed cyclic phenol sulfide, and charge control agent and toner using same | HODOGAYA CHEMICAL CO LTD (JP) | 2009-06-10 | — | — | CN | disclosed |
| CN-100402504-C | Monoazo iron complex compound, charge control agent containing the same, and toner | HODOGAYA CHEMICAL CO LTD (JP) | 2008-07-16 | — | — | CN | disclosed |
| CN-101103314-A | Toner | CANON KK (JP) | 2008-01-09 | — | — | CN | disclosed |
| CN-1983041-A | Toner | CANON KK (JP) | 2007-06-20 | — | — | CN | disclosed |
| CN-1759102-A | Monoazo iron complex compound, charge control agent containing the same, and toner | HODOGAYA CHEMICAL CO LTD (JP) | 2006-04-12 | — | — | CN | disclosed |
| CN-1550917-A | Color toner | ������������ʽ���� | 2004-12-01 | — | — | CN | disclosed |
| CN-1109982-A | Toner for developing electrostatic image | CANON KK (JP) | 1995-10-11 | — | — | CN | disclosed |
| EP-0631572-A1 | OXIMATION PROCESS | HENKEL CORPORATION (US) | 1995-01-04 | — | — | EP | disclosed |
| WO-1993019041-A1 | OXIMATION PROCESS | HENKEL CORPORATION (US) | 1993-09-30 | — | — | WO | disclosed |